Pulse Biosciences Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
Pulse Biosciences, Inc. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Revenue & Gross Profit
Revenue0.000.000.701.420.000.000.00
Cost of Revenue0.000.0011.941.970.500.600.00
Gross Profit0.000.00-11.24-0.55-0.50-0.600.00
Operating Expenses
Research & Development32.3427.8020.8428.6426.4424.9617.25
Selling, General & Administrative23.9215.7825.9733.8223.5222.3320.05
Operating Expenses56.2643.5746.8162.4649.9747.9537.96
Operating Income-56.26-43.57-58.06-63.01-49.97-46.97-37.96
Other Income/Expense
Interest Income2.672.460.640.050.230.000.45
Interest Expense0.00-1.10-0.90-0.700.000.000.00
Other Income/Expense2.670.000.000.000.000.00-0.03
Income
Income Before Tax-53.59-42.21-58.51-63.66-49.85-46.97-37.55
Income Tax Expense0.000.000.000.000.000.000.00
Net Income-53.59-42.21-58.51-63.66-49.85-46.97-37.55
Net Income - Continuous Operations-53.59-42.21-58.51-63.660.000.000.00
Net Income - Discontinued Operations0.000.000.000.000.000.000.00
EBITDA-55.08-42.37-56.70-61.87-48.87-46.79-36.65
EBIT-56.26-43.57-58.06-63.01-49.97-47.95-37.96
Depreciation & Amortization1.181.211.361.151.100.670.67
Earnings Per Share
Basic EPS-1.00-1.00-2.00-2.00-2.00--2.00
Diluted EPS-1.00-1.00-2.00-2.00-2.00-2.00-2.00
Basic Shares Outstanding58.4049.7434.5127.9623.2520.7517.08
Diluted Shares Outstanding58.4049.7434.5127.9623.2520.7517.08